LATEST NEWS

U-Liberman-IOF-board-member-in-memoriam

It is with great sadness that IOF announces the passing of Professor Uri A. Liberman, M.D., Ph.D. on November 13, 2022. Prof. Liberman was Professor of Physiology and Medicine at Tel Aviv University Department of Physiology and Pharmacology.
IOF was greatly honoured to count Professor Liberman as a Founding Board member (from 1998-2011) and as a member of its Scientific Advisory Committee (CSA) since 1998.  With his passing, the bone field has lost a renowned researcher and outstanding physician in internal medicine and endocrinology who contributed greatly to the field of bone metabolism over several decades. He will be greatly missed by his many colleagues around the world who had the privilege of working and studying with him through a long and fruitful international career.

Prof. Liberman studied medicine at the Hadassah School of Medicine and the Hebrew University in Jerusalem and did research for a PhD at the University of California, San Francisco, USA. He was a visiting scientist at the US National Institute of Health and visiting lecturer at various universities in the US, Europe, South America and Japan. He was Director of the first metabolic unit established in Israel and rotating director of the Institute of Endocrinology and Metabolic Diseases at the Rabin-Bilinson Medical Center. Prof. Liberman received national and international research awards, including the IBMS John G. Haddad Jr. Award in 2001. He published over 150 articles in leading international medical journals, as well as text book chapters in endocrinology and bone and mineral metabolism. 

As well as his role as IOF Board and CSA member, Professor Liberman was very active in many bone-related organizations during his lifetime. He was Past-President of the Israeli Bone and Mineral Society and the Israeli Osteoporosis Association, Executive Committee Chairman of the Israel Foundation for Osteoporosis and Bone Diseases, a member of the World Health Organization (WHO) Task Force on Osteoporosis, Member of the science board of the Paget's Disease Foundation since 1992, and a member of the ASBMR since its founding. 

He will be remembered not only for his many contributions to the bone field, but also as a kind and thoughtful colleague. We extend our heartfelt condolences to Prof. Lieberman’s family and friends.